table of content
1 Study Coverage
1.1 Remicade Biosimilar Product Introduction
1.2 Global Remicade Biosimilar Outlook 2017 VS 2022 VS 2028
1.2.1 Global Remicade Biosimilar Sales in US$ Million for the Year 2017-2028
1.2.2 Global Remicade Biosimilar Sales in Volume for the Year 2017-2028
1.3 United States Remicade Biosimilar Outlook 2017 VS 2022 VS 2028
1.3.1 United States Remicade Biosimilar Sales in US$ Million for the Year 2017-2028
1.3.2 United States Remicade Biosimilar Sales in Volume for the Year 2017-2028
1.4 Remicade Biosimilar Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Remicade Biosimilar in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Remicade Biosimilar Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Remicade Biosimilar Market Dynamics
1.5.1 Remicade Biosimilar Industry Trends
1.5.2 Remicade Biosimilar Market Drivers
1.5.3 Remicade Biosimilar Market Challenges
1.5.4 Remicade Biosimilar Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Remicade Biosimilar Market Segment by Type
2.1.1 100mg/10ml
2.1.2 500mg/50ml
2.2 Global Remicade Biosimilar Market Size by Type
2.2.1 Global Remicade Biosimilar Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Remicade Biosimilar Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Remicade Biosimilar Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Remicade Biosimilar Market Size by Type
2.3.1 United States Remicade Biosimilar Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Remicade Biosimilar Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Remicade Biosimilar Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Remicade Biosimilar Market Segment by Application
3.1.1 Blood Disorders
3.1.2 Oncology Diseases
3.2 Global Remicade Biosimilar Market Size by Application
3.2.1 Global Remicade Biosimilar Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Remicade Biosimilar Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Remicade Biosimilar Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Remicade Biosimilar Market Size by Application
3.3.1 United States Remicade Biosimilar Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Remicade Biosimilar Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Remicade Biosimilar Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Remicade Biosimilar Competitor Landscape by Company
4.1 Global Remicade Biosimilar Market Size by Company
4.1.1 Top Global Remicade Biosimilar Manufacturers Ranked by Revenue (2021)
4.1.2 Global Remicade Biosimilar Revenue by Manufacturer (2017-2022)
4.1.3 Global Remicade Biosimilar Sales by Manufacturer (2017-2022)
4.1.4 Global Remicade Biosimilar Price by Manufacturer (2017-2022)
4.2 Global Remicade Biosimilar Concentration Ratio (CR)
4.2.1 Remicade Biosimilar Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Remicade Biosimilar in 2021
4.2.3 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Remicade Biosimilar Manufacturing Base Distribution, Product Type
4.3.1 Global Remicade Biosimilar Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Remicade Biosimilar Product Type
4.3.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Remicade Biosimilar Market Size by Company
4.5.1 Top Remicade Biosimilar Players in United States, Ranked by Revenue (2021)
4.5.2 United States Remicade Biosimilar Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Remicade Biosimilar Sales by Players (2020, 2021 & 2022)
5 Global Remicade Biosimilar Market Size by Region
5.1 Global Remicade Biosimilar Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Remicade Biosimilar Market Size in Volume by Region (2017-2028)
5.2.1 Global Remicade Biosimilar Sales in Volume by Region: 2017-2022
5.2.2 Global Remicade Biosimilar Sales in Volume Forecast by Region (2023-2028)
5.3 Global Remicade Biosimilar Market Size in Value by Region (2017-2028)
5.3.1 Global Remicade Biosimilar Sales in Value by Region: 2017-2022
5.3.2 Global Remicade Biosimilar Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Remicade Biosimilar Market Size YoY Growth 2017-2028
6.1.2 North America Remicade Biosimilar Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Remicade Biosimilar Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Remicade Biosimilar Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Remicade Biosimilar Market Size YoY Growth 2017-2028
6.3.2 Europe Remicade Biosimilar Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Remicade Biosimilar Market Size YoY Growth 2017-2028
6.4.2 Latin America Remicade Biosimilar Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Remicade Biosimilar Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Synthon Pharmaceuticals
7.1.1 Synthon Pharmaceuticals Corporation Information
7.1.2 Synthon Pharmaceuticals Description and Business Overview
7.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
7.1.5 Synthon Pharmaceuticals Recent Development
7.2 LG Life Sciences
7.2.1 LG Life Sciences Corporation Information
7.2.2 LG Life Sciences Description and Business Overview
7.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.2.4 LG Life Sciences Remicade Biosimilar Products Offered
7.2.5 LG Life Sciences Recent Development
7.3 Novartis (Sandoz)
7.3.1 Novartis (Sandoz) Corporation Information
7.3.2 Novartis (Sandoz) Description and Business Overview
7.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
7.3.5 Novartis (Sandoz) Recent Development
7.4 Celltrion
7.4.1 Celltrion Corporation Information
7.4.2 Celltrion Description and Business Overview
7.4.3 Celltrion Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Celltrion Remicade Biosimilar Products Offered
7.4.5 Celltrion Recent Development
7.5 Biocon
7.5.1 Biocon Corporation Information
7.5.2 Biocon Description and Business Overview
7.5.3 Biocon Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Biocon Remicade Biosimilar Products Offered
7.5.5 Biocon Recent Development
7.6 Hospira
7.6.1 Hospira Corporation Information
7.6.2 Hospira Description and Business Overview
7.6.3 Hospira Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Hospira Remicade Biosimilar Products Offered
7.6.5 Hospira Recent Development
7.7 Merck Serono (Merck Group)
7.7.1 Merck Serono (Merck Group) Corporation Information
7.7.2 Merck Serono (Merck Group) Description and Business Overview
7.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
7.7.5 Merck Serono (Merck Group) Recent Development
7.8 Biogen idec Inc.
7.8.1 Biogen idec Inc. Corporation Information
7.8.2 Biogen idec Inc. Description and Business Overview
7.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
7.8.5 Biogen idec Inc. Recent Development
7.9 Genentech (Roche Group)
7.9.1 Genentech (Roche Group) Corporation Information
7.9.2 Genentech (Roche Group) Description and Business Overview
7.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
7.9.5 Genentech (Roche Group) Recent Development
7.10 Fosun Pharmaceutical
7.10.1 Fosun Pharmaceutical Corporation Information
7.10.2 Fosun Pharmaceutical Description and Business Overview
7.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Fosun Pharmaceutical Remicade Biosimilar Products Offered
7.10.5 Fosun Pharmaceutical Recent Development
7.11 Livzon Pharmaceutical
7.11.1 Livzon Pharmaceutical Corporation Information
7.11.2 Livzon Pharmaceutical Description and Business Overview
7.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Livzon Pharmaceutical Remicade Biosimilar Products Offered
7.11.5 Livzon Pharmaceutical Recent Development
7.12 Anke Biotechnology
7.12.1 Anke Biotechnology Corporation Information
7.12.2 Anke Biotechnology Description and Business Overview
7.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Anke Biotechnology Products Offered
7.12.5 Anke Biotechnology Recent Development
7.13 Hualan Biological Engineering
7.13.1 Hualan Biological Engineering Corporation Information
7.13.2 Hualan Biological Engineering Description and Business Overview
7.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Hualan Biological Engineering Products Offered
7.13.5 Hualan Biological Engineering Recent Development
7.14 Walvax Biotechnology
7.14.1 Walvax Biotechnology Corporation Information
7.14.2 Walvax Biotechnology Description and Business Overview
7.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Walvax Biotechnology Products Offered
7.14.5 Walvax Biotechnology Recent Development
7.15 Hisun Pharmaceutical
7.15.1 Hisun Pharmaceutical Corporation Information
7.15.2 Hisun Pharmaceutical Description and Business Overview
7.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Hisun Pharmaceutical Products Offered
7.15.5 Hisun Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Remicade Biosimilar Industry Chain Analysis
8.2 Remicade Biosimilar Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Remicade Biosimilar Distributors
8.3 Remicade Biosimilar Production Mode & Process
8.4 Remicade Biosimilar Sales and Marketing
8.4.1 Remicade Biosimilar Sales Channels
8.4.2 Remicade Biosimilar Distributors
8.5 Remicade Biosimilar Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
